These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32590173)

  • 1. Less Is More: Novel Hepatocyte-Targeted siRNA Conjugates for Treatment of Liver-Related Disorders.
    Weingärtner A; Bethge L; Weiss L; Sternberger M; Lindholm MW
    Mol Ther Nucleic Acids; 2020 Sep; 21():242-250. PubMed ID: 32590173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways.
    Kandasamy P; Mori S; Matsuda S; Erande N; Datta D; Willoughby JLS; Taneja N; O'Shea J; Bisbe A; Manoharan RM; Yucius K; Nguyen T; Indrakanti R; Gupta S; Gilbert JA; Racie T; Chan A; Liu J; Hutabarat R; Nair JK; Charisse K; Maier MA; Rajeev KG; Egli M; Manoharan M
    J Med Chem; 2023 Feb; 66(4):2506-2523. PubMed ID: 36757090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo.
    Rajeev KG; Nair JK; Jayaraman M; Charisse K; Taneja N; O'Shea J; Willoughby JL; Yucius K; Nguyen T; Shulga-Morskaya S; Milstein S; Liebow A; Querbes W; Borodovsky A; Fitzgerald K; Maier MA; Manoharan M
    Chembiochem; 2015 Apr; 16(6):903-8. PubMed ID: 25786782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes.
    Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M
    ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases.
    Li Q; Yin K; Ma HP; Liu HH; Li S; Luo X; Hu R; Zhang WW; Lv ZS; Niu XL; Gu MH; Li CL; Liu YS; Liu YJ; Li HB; Li N; Li C; Gu WW; Li JJ
    Mol Ther; 2024 Mar; 32(3):637-645. PubMed ID: 38204163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
    Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
    Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.
    Prakash TP; Graham MJ; Yu J; Carty R; Low A; Chappell A; Schmidt K; Zhao C; Aghajan M; Murray HF; Riney S; Booten SL; Murray SF; Gaus H; Crosby J; Lima WF; Guo S; Monia BP; Swayze EE; Seth PP
    Nucleic Acids Res; 2014 Jul; 42(13):8796-807. PubMed ID: 24992960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of GalNAc-Conjugated Antisense Oligonucleotide Metabolites Using an Untargeted and Generic Approach Based on High Resolution Mass Spectrometry.
    Husser C; Brink A; Zell M; Müller MB; Koller E; Schadt S
    Anal Chem; 2017 Jun; 89(12):6821-6826. PubMed ID: 28520401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of GalNAc-Oligonucleotide Conjugates Using GalNAc Phosphoramidite and Triple-GalNAc CPG Solid Support.
    Ulashchik EA; Martynenko-Makaev YV; Akhlamionok TP; Melnik DM; Shmanai VV; Zatsepin TS
    Methods Mol Biol; 2021; 2282():101-118. PubMed ID: 33928572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-Specific Delivery of Peptide Nucleic Acids Conjugated to Three Sequentially Linked
    Bhingardeve P; Madhanagopal BR; Naick H; Jain P; Manoharan M; Ganesh K
    J Org Chem; 2020 Jul; 85(14):8812-8824. PubMed ID: 32529829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
    Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
    J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5'-GalNAc-Conjugated Oligonucleotides: A Comparison of Solid and Solution-Phase Conjugation Strategies.
    Cedillo I; Chreng D; Engle E; Chen L; McPherson AK; Rodriguez AA
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28809818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Synthesis and Biological Evaluation of 5'-GalNAc Conjugated Antisense Oligonucleotides.
    Østergaard ME; Yu J; Kinberger GA; Wan WB; Migawa MT; Vasquez G; Schmidt K; Gaus HJ; Murray HM; Low A; Swayze EE; Prakash TP; Seth PP
    Bioconjug Chem; 2015 Aug; 26(8):1451-5. PubMed ID: 26011654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure Tuning of Cationic Oligospermine-siRNA Conjugates for Carrier-Free Gene Silencing.
    Nothisen M; Bagilet J; Behr JP; Remy JS; Kotera M
    Mol Pharm; 2016 Aug; 13(8):2718-28. PubMed ID: 27398779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase synthesis of 5'-triantennary N-acetylgalactosamine conjugated antisense oligonucleotides using phosphoramidite chemistry.
    Prakash TP; Brad Wan W; Low A; Yu J; Chappell AE; Gaus H; Kinberger GA; Østergaard ME; Migawa MT; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4127-30. PubMed ID: 26299345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.
    Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M
    J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Uptake of Antisense Oligonucleotides in Mouse Hepatocytes and Macrophages Revealed by Simultaneous Two-Photon Excited Fluorescence and Coherent Raman Imaging.
    Mukherjee P; Aksamitiene E; Alex A; Shi J; Bera K; Zhang C; Spillman DR; Marjanovic M; Fazio M; Seth PP; Frazier K; Hood SR; Boppart SA
    Nucleic Acid Ther; 2022 Jun; 32(3):163-176. PubMed ID: 34797690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides.
    Yamamoto T; Sawamura M; Wada F; Harada-Shiba M; Obika S
    Bioorg Med Chem; 2016 Jan; 24(1):26-32. PubMed ID: 26678173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate.
    Zimmermann TS; Karsten V; Chan A; Chiesa J; Boyce M; Bettencourt BR; Hutabarat R; Nochur S; Vaishnaw A; Gollob J
    Mol Ther; 2017 Jan; 25(1):71-78. PubMed ID: 28129130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for Genotoxicity.
    Janas MM; Jiang Y; Duncan RG; Hayes AN; Liu J; Kasperkovitz PV; Placke ME; Barros SA
    Nucleic Acid Ther; 2016 Dec; 26(6):363-371. PubMed ID: 27387336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.